MX360450B - Mejoras de y relacionadas con composiciones. - Google Patents

Mejoras de y relacionadas con composiciones.

Info

Publication number
MX360450B
MX360450B MX2013008635A MX2013008635A MX360450B MX 360450 B MX360450 B MX 360450B MX 2013008635 A MX2013008635 A MX 2013008635A MX 2013008635 A MX2013008635 A MX 2013008635A MX 360450 B MX360450 B MX 360450B
Authority
MX
Mexico
Prior art keywords
preserved
relating
compositions
solutions
constipation
Prior art date
Application number
MX2013008635A
Other languages
English (en)
Spanish (es)
Other versions
MX2013008635A (es
Inventor
Seldon Chris
Padfield Dawn
Morrissey Frances
Original Assignee
Norgine Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1101666.4A external-priority patent/GB201101666D0/en
Priority claimed from GBGB1101738.1A external-priority patent/GB201101738D0/en
Priority claimed from GBGB1200637.5A external-priority patent/GB201200637D0/en
Application filed by Norgine Bv filed Critical Norgine Bv
Publication of MX2013008635A publication Critical patent/MX2013008635A/es
Publication of MX360450B publication Critical patent/MX360450B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/77Polymers containing oxygen of oxiranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
MX2013008635A 2011-01-31 2012-01-31 Mejoras de y relacionadas con composiciones. MX360450B (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB1101666.4A GB201101666D0 (en) 2011-01-31 2011-01-31 Improvements in and relating to compositions
GBGB1101738.1A GB201101738D0 (en) 2011-02-01 2011-02-01 Improvements in and relating to compositions
GBGB1200637.5A GB201200637D0 (en) 2012-01-13 2012-01-13 Improvements in and relating to compositions
PCT/GB2012/050195 WO2012104617A1 (en) 2011-01-31 2012-01-31 Improvements in and relating to compositions

Publications (2)

Publication Number Publication Date
MX2013008635A MX2013008635A (es) 2013-11-04
MX360450B true MX360450B (es) 2018-11-01

Family

ID=45563438

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013008635A MX360450B (es) 2011-01-31 2012-01-31 Mejoras de y relacionadas con composiciones.

Country Status (17)

Country Link
EP (2) EP2862566B1 (enExample)
JP (2) JP2014504628A (enExample)
KR (1) KR101852502B1 (enExample)
CN (2) CN103458874A (enExample)
AU (1) AU2012213180B2 (enExample)
BR (1) BR112013019418B1 (enExample)
CY (1) CY1125270T1 (enExample)
DE (1) DE202012013349U1 (enExample)
DK (1) DK2862566T3 (enExample)
EA (1) EA028925B1 (enExample)
ES (1) ES2914034T3 (enExample)
HR (1) HRP20220691T1 (enExample)
MX (1) MX360450B (enExample)
PL (1) PL2862566T3 (enExample)
PT (1) PT2862566T (enExample)
WO (1) WO2012104617A1 (enExample)
ZA (1) ZA201305342B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
MX382868B (es) 2012-09-11 2025-03-13 Norgine Bv Composiciones que comprenden polietilenglicol y ascorbato.
CN108904462A (zh) 2013-03-15 2018-11-30 布伦特里实验室公司 双用途硫酸盐口服药物组合物片剂及其使用方法
WO2016208781A1 (ko) * 2015-06-22 2016-12-29 주식회사 씨티씨바이오 장관 세척용 하제 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002335900A1 (en) * 2001-10-29 2003-05-12 Shimizu Pharmaceutical Co., Ltd. Bowel cleansing agent
JP2007511610A (ja) * 2003-11-17 2007-05-10 ブレーントリー ラボラトリーズ インコーポレーティッド 治療用peg溶液濃縮物
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
WO2006122104A1 (en) * 2005-05-06 2006-11-16 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
GB0912487D0 (en) * 2009-07-17 2009-08-26 Norgine Bv Improvements in and relating to colon cleansing compositions
GB0913295D0 (en) * 2009-07-30 2009-09-02 Norgine Bv Improvements in and relating to pharmaceutical compositions

Also Published As

Publication number Publication date
DE202012013349U1 (de) 2016-06-27
PT2862566T (pt) 2022-06-02
EP2862566A1 (en) 2015-04-22
CY1125270T1 (el) 2024-12-13
CN107260661A (zh) 2017-10-20
EA028925B1 (ru) 2018-01-31
DK2862566T3 (da) 2022-05-16
PL2862566T3 (pl) 2022-06-20
BR112013019418A2 (enExample) 2017-08-29
ZA201305342B (en) 2014-12-23
BR112013019418B1 (pt) 2022-03-29
JP2014504628A (ja) 2014-02-24
HRP20220691T1 (hr) 2022-07-08
JP6498250B2 (ja) 2019-04-10
JP2018035181A (ja) 2018-03-08
ES2914034T3 (es) 2022-06-07
CN103458874A (zh) 2013-12-18
EP2670391A1 (en) 2013-12-11
KR101852502B1 (ko) 2018-04-26
MX2013008635A (es) 2013-11-04
WO2012104617A1 (en) 2012-08-09
EA201300882A1 (ru) 2014-01-30
KR20140007881A (ko) 2014-01-20
EP2862566B1 (en) 2022-03-09
NZ613401A (en) 2016-03-31
AU2012213180B2 (en) 2017-04-13

Similar Documents

Publication Publication Date Title
TN2012000161A1 (en) Spiro-oxindole mdm2 antagonists
PH12013500955A1 (en) Spiro-oxindole mdm2 antagonists
PH12015501336A1 (en) Personal cleansing compositions containing zinc amino acid/trimethylglycine halide
PH12013500449A1 (en) Treatment of diseases
AU2012265219A8 (en) Compounds containing hydrido-tricyano-borate anions
IN2015DN02729A (enExample)
CY1125270T1 (el) Βελτιωσεις σε και σχετιζομενες με συνθεσεις
MY182983A (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
MY161601A (en) Films and compositions comprising the same
PH12013501365A1 (en) Glycols as pathogen inactivating agents
EP2583969A4 (en) NEW RHODANINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING AIDS WITH THE RHODANIN DERIVATIVES AS ACTIVE AGENTS
EA201201239A1 (ru) Композиция, содержащая в качестве активного ингредиента l-карнитин в комбинации с гидроксикинуренин-о-бета-dl-глюкозидом, для предотвращения и/или лечения патологий глаза, вызванных ультрафиолетовым излучением
MX2013004062A (es) Analogos de ciclosporina.
HK1215391A1 (zh) 使用胎盘细胞外基质治疗口腔病变
WO2013055889A3 (en) Implantable scaffolds and methods of use
MX359713B (es) Composiciones mejoradas para la cicatrizacion de heridas que comprenden microesferas.
HK1216504A1 (zh) 疾病的治療方法
MX2013007055A (es) Derivados de sanglifehrina y metodos para su produccion.
WO2010149283A3 (de) Phenyloxy(thio)phenylamidbenzoxa(thia)zole
AR089615A1 (es) Peptidos antimicrobianos, composiciones que los comprenden y usos
WO2012108748A3 (ko) 합환피 추출물을 포함하는 뇌암 치료용 조성물 및 화장료 조성물
MX2013009456A (es) Compuestos de azufre aromaticos sustituidos y metodos para su uso.
PH12012502054A1 (en) Dithiinopyridazine-dion derivatives
TN2011000352A1 (en) New combination of active ingredients containing a non steroidal anti inflammatory drug and a colchicoside derivative
GB2491084A (en) Compounds for the treatment of renal cell carcinoma

Legal Events

Date Code Title Description
FG Grant or registration